Skip to main content
. 2016 Sep 16;21(9):1241. doi: 10.3390/molecules21091241

Table 5.

Inhibitory effect of isolated compounds from X. strumarium on advanced glycation end products (AGEs).

Entry Products Concentration (μg/mL) Inhibition (%) IC50 1 (μg/mL)
Aminoguanidine 2 400 98.17 155.88 ± 15.45 (1410.00 μM)
200 61.01
100 37.84
50 27.97
1 Protocatechuic acid 100 9.49 -
2 3-Hydroxy-1-(4-hydroxy phenyl) propan-1-one 100 8.50 -
3 Cytidine 100 33.16 -
4 Neochlorogenic acid methyl ester 100 11.40 -
5 Chlorogenic acid 100 7.47 -
6 Methyl-3,5-di-O-caffeoylquinic acid 100 89.47 43.96 ± 3.89 (82.79 μM)
50 54.77
20 34.59
10 24.24
7 Thiazine-3,5-dione-11-O-glucopyranoside 100 22.24 -
8 Patuletin-3-glucuronide 100 6.11 -
9 Quercetin-3-O-glucuronide 100 23.96 -
10 3,5-Di-O-caffeoylquinic acid 100 42.91 -
11 1,5-Di-O-caffeoylquinic acid 100 25.04 -
12 1,3-Di-O-caffeoylquinic acid 100 40.19 -
13 1,3,5-Tri-O-caffeoylquinic acid 100 40.22 -
14 Raffinose 100 14.99 -

1 The IC50 value was defined as the half-maximal inhibitory concentration and mean of 3 duplication analyses of each sample. 2 Aminoguanidine was used as the positive control. - is no activity.

HHS Vulnerability Disclosure